standard approach to treating dlbcl
Published 4 years ago • 293 plays • Length 4:44Download video MP4
Download video MP3
Similar videos
-
4:05
selecting therapy for relapsed-refractory dlbcl
-
6:43
current treatment approach to relapsed/refractory dlbcl
-
20:48
current upfront management of dlbcl
-
3:15
treatment limitations in dlbcl
-
4:46
treatment of r/r dlbcl: cd19-targeted monoclonal antibodies
-
2:54
selecting therapy for relapsed-refractory dlbcl
-
4:31
using novel therapy in relapsed-refractory dlbcl
-
4:30
an expert overview of dlbcl treatment approaches
-
54:13
treatment options for dlbcl
-
21:56
what's new in the approach to dlbcl upfront and in the relapsed setting beyond car t
-
7:07
esmo expert video report on standard approaches and new treatment options for dlbcl
-
1:12
current treatment options for dlbcl besides r-chop chemotherapy
-
1:45
improving the frontline treatment of dlbcl
-
5:55
car t-cell therapy in dlbcl
-
4:32
how is relapsed/refractory dlbcl treated?
-
0:34
rationale for genetic testing in patients with dlbcl
-
3:37
how does your dlbcl subtype impact your treatment options?
-
1:24
unmet needs remain in the diffuse large b-cell lymphoma treatment paradigm
-
0:42
targeted therapies for dlbcl treatment